news
Machine learning used to predict most effective cancer drugs
According to a new study, Drug Ranking Using Machine Learning (DRUML) can accurately rank cancer therapies by efficacy across a range of cancer types.
List view / Grid view
Leukaemia
news
EMA recommends 15 medicines for approval following December meeting
The EMA's human medicines committee has released its results for the December meeting, suggesting which therapies should receive marketing authorisation.
news
Tinostamustine granted Orphan Drug Designation by European Commission
Tinostamustine has been granted Orphan Drug Designation by the European Commission to the treatment of T-cell prolymphocytic leukaemia (T-PLL).
news
China’s drug bulk-buy programme has been expanded
China has expanded a pilot drug bulk-buying programme to almost the entire country which is adding pressure on pharma companies.
news
FDA approval for leukaemia non-chemo combination therapy
The FDA has approved the first ever non-chemotherapy combination treatment using ibrutinib and obinutuzumab for the most common form of adult leukaemia...
news
NHS announces groundbreaking personalised child cancer treatment
The NHS has announced a groundbreaking new treatment, CAR-T, for children with leukaemia...
news
Scientists share promising results of BET and EZH2 inhibitors for lymphoma
Researchers at the TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris have presented new epigenetics compounds that show early activity in lymphoma patients.
news
Repurposing leukaemia drugs may prevent melanoma metastasis
Data from a new study shows that repurposing drugs used to treat leukaemia has promise for preventing melanoma metastasis...
news
Nanoshells could deliver more chemo with fewer side effects
In vitro study verifies method for remotely triggering release of cancer drugs...
news
Flu vaccine found to be ineffective in leukaemia patients
Leukaemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals...
news
Researchers discover new targets for approved cancer drug ceritinib
New study shows ALK inhibitor ceritinib may have the ability to be used for more than ALK-rearranged non-small cell lung cancer...
news
Sandoz receives EU approval in Europe for Rixathon (biosimilar rituximab)
The EC has approved Sandoz’ Rixathon (biosimilar rituximab) for use in Europe. Rixathon is approved for use in all indications of the reference medicine...
news
Price drop means leukaemia CDF drug will be routinely available
2 December 2016 | By Niamh Louise Marriott, Digital Editor
Ibrutinib had only previously been available through the CDF. Following a reduction in its price for the NHS, it is now recommended in further guidance...
news
Jazz Pharmaceuticals seeks FDA drug application approval for leukaemia treatment
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The company expects to complete the submission of the new drug application (NDA) for vyxeos by early 2017, and will request a priority review...
news
Blood cancer study yields disappointing results
19 July 2016 | By Niamh Louise Marriott
Gazyvaro did not meet its primary endpoint of significantly reducing the risk of disease worsening or death in people with diffuse large B-cell lymphoma...
